Asymptomatiske stigninger i serumtransaminaser, der i de fleste tilfælde var milde og forbigående, forekom meget almindeligt hos patienter, behandlet med Betaferon under kliniske studier.
Asymptomatic elevations of serum transaminases, in most cases mild and transient, occurred very commonly in patients treated with Betaferon during clinical trials.